In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
- 26 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (5), 2008-2013
- https://doi.org/10.1182/blood-2006-02-002055
Abstract
Despite considerable success in treating newly diagnosed childhood acute lymphoblastic leukemia (ALL), relapsed disease remains a significant clinical challenge. Using a NOD/SCID mouse xenograft model, we report that immunostimulatory DNA oligonucleotides containing CpG motifs (CpG ODNs) stimulate significant immune activity against primary human ALL cells in vivo. The administration of CpG ODNs induced a significant reduction in systemic leukemia burden, mediated continued disease control, and significantly improved survival of mice with established human ALL. The death of leukemia cells in vivo was independent of the ability of ALL cells to respond directly to CpG ODNs and correlated with the production of IL-12p70, IFN-α, and IFN-γ by the host. In addition, depletion of natural killer cells by anti–asialo-GM1 treatment significantly reduced the in vivo antileukemic activity of CpG ODN. This antileukemia effect was not limited to the xenograft model because natural killer cell–dependent killing of ALL by human peripheral blood mononuclear cells (PBMCs) was also increased by CpG ODN stimulation. These results suggest that CpG ODNs have potential as therapeutic agents for the treatment of ALL.Keywords
This publication has 54 references indexed in Scilit:
- CD40 activation of BCP-ALL cells generates IL-10–producing, IL-12–defective APCs that induce allogeneic T-cell anergyBlood, 2004
- Adult acute lymphoblastic leukaemiaCritical Reviews in Oncology/Hematology, 2004
- CpG Oligonucleotides Elicit Antitumor Responses in a Human Melanoma NOD/SCID Xenotransplantation ModelJournal of Investigative Dermatology, 2004
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- CHILDHOOD ALL BLASTS RETAIN PHENOTYPIC AND GENOTYPIC CHARACTERISTICS UPON LONG-TERM SERIAL PASSAGE IN NOD/SCID MICEPediatric Hematology and Oncology, 2000
- Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphomaTransplantation and Cellular Therapy, 1999
- Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation. Superior survival following transplantation with matched unrelated donor graftsBone Marrow Transplantation, 1998
- Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experienceBritish Journal of Haematology, 1998
- Loss of natural killer activity as an indicator of relapse in acute leukaemiaClinical and Experimental Immunology, 1990